Presentation of the Innovation Prize
As part of this year's German Biotechnology Days (DBT) in Berlin, the award ceremony for the Bioregions Innovation Prize was once again held on 16.04.2024.
April 17, 2024
News
As part of this year's German Biotechnology Days (DBT) in Berlin, the award ceremony for the Bioregions Innovation Prize was once again held on 16.04.2024.
The Working Group of BioRegions of Germany has been awarding the Innovation Prize for innovative patents in biotechnology, bioeconomy and medical technology for 17 years. This year's prize winners are teams from Duisburg/Essen, Berlin/Schiffweiler (Saarland) and Würzburg.
The six finalists presented their research projects to an international audience of experts, potential investors and the trade press. The prize winners selected by a jury of experts were then announced. The three equivalent prizes, worth 2,000 euros each, went to researchers from Duisburg/Essen, Berlin/Schiffweiler (Saarland) and Würzburg.
One of the three prize winners is the team led by Prof. Dr. Bernd Giebel from the University of Essen/Duisburg and the start-up Exosla, which was honored for their project “Extracellular Vesicles: Cell-Free Stem Cell Therapy 2.0.” The underlying patent describes the immortalization of primary mesenchymal stem cells (MSC) using a novel method and thus creates the basis for making this highly potential therapeutic approach available for widespread use for the first time.
The 2024 winners also include the project “Bifunctional Peptides to Combat Pathogens” by the team led by Dr. Anja Himmelstein and Dr. Marius Hittinger from Freie Universität Berlin and the start-up MucoSaTec. The patent includes novel bifunctional peptides, which provide a flexible and cost-effective method for fighting viral infections. The peptides bind both to the pathogen and to the mucous membranes of the body and thus immobilize the microbes.
The third prize went to the “FungiMAB” project by the team led by PD Dr. med. Niklas Beyersdorf and Dr. Daniela Langenhorst and from the University of Würzburg. The patent describes novel monoclonal antibodies that act specifically against immune evasion proteins from fungal pathogens. This overrides their very own function of deceiving the immune system. This platform technology thus creates completely new approaches for treating fungal infections.
The laudatory speeches for the respective prize winners were once again given by the prize money sponsors. This year, it was Dr. Christine Schreiber from Springer Nature, Dr. Florian Rückerl from Dehmel-Bettenhausen Patentanwälte and Dr. Angelika Vlachou from High-Tech Gründerfonds.
In addition, the finalists once again had the opportunity to win another award — the Audience Award 2024. Following the presentations, the audience was able to vote for their favorite project via online voting. Dr. Uwe Freudenberg from Dresden emerged as the audience winner with his project “Polymer Materials to Cure Inflammatory Diseases.”
Dr. Andreas Schneider and Dr. Benjamin Aberle from Stuttgart completed the field of finalists with their project “New to nature production of terpenes from cyclases” and Dr. Nikolai Jaschke from Dresden with the topic “CBP/p300 HAS inhibition for the treatment of neutropenic fever.” Dr. Julia Behnke, who won the 2019 Innovation Prize and reported on her future journey since then, also gave an exciting impetus.
Dr. Cathrin Dierkes and André van Hall from the organizing BioRegions BioIndustry and BioCologne moderated the award ceremony. “We are pleased that, with the Working Group of Bioregions, we can once again contribute to providing innovative cutting-edge research from Germany a platform and thus becoming more visible,” says Cathrin Dierkes enthusiastically. André van Hall adds: “Fortunately, the basis of German biotechnology remains excellent. It is important to consistently develop the framework conditions for the sustainable success of biotechnology. ”
About the Innovation Prize
The Innovation Prize of the German BioRegions is an initiative of the Working Group of BioRegions. Each year, the working group honors the three most innovative (patented) research ideas in the life sciences. For example, the Innovation Prize of the German BioRegions promotes transfer between science and industry and strengthens public interest in biotechnological research.
More information: www.innovationspreis-der-bioregionen.de
About the BioRegions Working Group
The Working Group of BioRegions in Germany is a voluntary association of the German BioRegions and has its office at BIO Germany in Berlin. The 31 members deal with topics such as financing, start-up and technology transfer as well as the public image of the German biotechnology sector. Since 2007, AK BioRegio has been awarding the German Bioregions Innovation Prize, a nationwide competition for application-oriented ideas from universities, and, together with BIO Germany, organizes the German Biotechnology Days.
More information: www.biodeutschland.org/de/ak-bioregio.html
The Innovation Prize of the German BioRegions 2024 was sponsored by long-standing partners, Springer Verlag, Dehmel & Bettenhausen law firm and the High-Tech Gründerfonds and organized jointly by BioIndustry and BioCologne.
Press contact for the German BioRegions Working Group:
Working Group of BioRegions c/o BIO Germany e. V.
Schützenstraße 6a 10117 Berlin
email: info@ak-bioregio.org
Site: www.ak-bioregio.org
© Pictures: http://www.sera-photography.com/
Presentation of the Innovation Prize
As part of this year's German Biotechnology Days (DBT) in Berlin, the award ceremony for the Bioregions Innovation Prize was once again held on 16.04.2024.
April 17, 2024
News
As part of this year's German Biotechnology Days (DBT) in Berlin, the award ceremony for the Bioregions Innovation Prize was once again held on 16.04.2024.
The Working Group of BioRegions of Germany has been awarding the Innovation Prize for innovative patents in biotechnology, bioeconomy and medical technology for 17 years. This year's prize winners are teams from Duisburg/Essen, Berlin/Schiffweiler (Saarland) and Würzburg.
The six finalists presented their research projects to an international audience of experts, potential investors and the trade press. The prize winners selected by a jury of experts were then announced. The three equivalent prizes, worth 2,000 euros each, went to researchers from Duisburg/Essen, Berlin/Schiffweiler (Saarland) and Würzburg.
One of the three prize winners is the team led by Prof. Dr. Bernd Giebel from the University of Essen/Duisburg and the start-up Exosla, which was honored for their project “Extracellular Vesicles: Cell-Free Stem Cell Therapy 2.0.” The underlying patent describes the immortalization of primary mesenchymal stem cells (MSC) using a novel method and thus creates the basis for making this highly potential therapeutic approach available for widespread use for the first time.
The 2024 winners also include the project “Bifunctional Peptides to Combat Pathogens” by the team led by Dr. Anja Himmelstein and Dr. Marius Hittinger from Freie Universität Berlin and the start-up MucoSaTec. The patent includes novel bifunctional peptides, which provide a flexible and cost-effective method for fighting viral infections. The peptides bind both to the pathogen and to the mucous membranes of the body and thus immobilize the microbes.
The third prize went to the “FungiMAB” project by the team led by PD Dr. med. Niklas Beyersdorf and Dr. Daniela Langenhorst and from the University of Würzburg. The patent describes novel monoclonal antibodies that act specifically against immune evasion proteins from fungal pathogens. This overrides their very own function of deceiving the immune system. This platform technology thus creates completely new approaches for treating fungal infections.
The laudatory speeches for the respective prize winners were once again given by the prize money sponsors. This year, it was Dr. Christine Schreiber from Springer Nature, Dr. Florian Rückerl from Dehmel-Bettenhausen Patentanwälte and Dr. Angelika Vlachou from High-Tech Gründerfonds.
In addition, the finalists once again had the opportunity to win another award — the Audience Award 2024. Following the presentations, the audience was able to vote for their favorite project via online voting. Dr. Uwe Freudenberg from Dresden emerged as the audience winner with his project “Polymer Materials to Cure Inflammatory Diseases.”
Dr. Andreas Schneider and Dr. Benjamin Aberle from Stuttgart completed the field of finalists with their project “New to nature production of terpenes from cyclases” and Dr. Nikolai Jaschke from Dresden with the topic “CBP/p300 HAS inhibition for the treatment of neutropenic fever.” Dr. Julia Behnke, who won the 2019 Innovation Prize and reported on her future journey since then, also gave an exciting impetus.
Dr. Cathrin Dierkes and André van Hall from the organizing BioRegions BioIndustry and BioCologne moderated the award ceremony. “We are pleased that, with the Working Group of Bioregions, we can once again contribute to providing innovative cutting-edge research from Germany a platform and thus becoming more visible,” says Cathrin Dierkes enthusiastically. André van Hall adds: “Fortunately, the basis of German biotechnology remains excellent. It is important to consistently develop the framework conditions for the sustainable success of biotechnology. ”
About the Innovation Prize
The Innovation Prize of the German BioRegions is an initiative of the Working Group of BioRegions. Each year, the working group honors the three most innovative (patented) research ideas in the life sciences. For example, the Innovation Prize of the German BioRegions promotes transfer between science and industry and strengthens public interest in biotechnological research.
More information: www.innovationspreis-der-bioregionen.de
About the BioRegions Working Group
The Working Group of BioRegions in Germany is a voluntary association of the German BioRegions and has its office at BIO Germany in Berlin. The 31 members deal with topics such as financing, start-up and technology transfer as well as the public image of the German biotechnology sector. Since 2007, AK BioRegio has been awarding the German Bioregions Innovation Prize, a nationwide competition for application-oriented ideas from universities, and, together with BIO Germany, organizes the German Biotechnology Days.
More information: www.biodeutschland.org/de/ak-bioregio.html
The Innovation Prize of the German BioRegions 2024 was sponsored by long-standing partners, Springer Verlag, Dehmel & Bettenhausen law firm and the High-Tech Gründerfonds and organized jointly by BioIndustry and BioCologne.
Press contact for the German BioRegions Working Group:
Working Group of BioRegions c/o BIO Germany e. V.
Schützenstraße 6a 10117 Berlin
email: info@ak-bioregio.org
Site: www.ak-bioregio.org
© Pictures: http://www.sera-photography.com/
Presentation of the Innovation Prize
As part of this year's German Biotechnology Days (DBT) in Berlin, the award ceremony for the Bioregions Innovation Prize was once again held on 16.04.2024.
April 17, 2024
News
As part of this year's German Biotechnology Days (DBT) in Berlin, the award ceremony for the Bioregions Innovation Prize was once again held on 16.04.2024.
The Working Group of BioRegions of Germany has been awarding the Innovation Prize for innovative patents in biotechnology, bioeconomy and medical technology for 17 years. This year's prize winners are teams from Duisburg/Essen, Berlin/Schiffweiler (Saarland) and Würzburg.
The six finalists presented their research projects to an international audience of experts, potential investors and the trade press. The prize winners selected by a jury of experts were then announced. The three equivalent prizes, worth 2,000 euros each, went to researchers from Duisburg/Essen, Berlin/Schiffweiler (Saarland) and Würzburg.
One of the three prize winners is the team led by Prof. Dr. Bernd Giebel from the University of Essen/Duisburg and the start-up Exosla, which was honored for their project “Extracellular Vesicles: Cell-Free Stem Cell Therapy 2.0.” The underlying patent describes the immortalization of primary mesenchymal stem cells (MSC) using a novel method and thus creates the basis for making this highly potential therapeutic approach available for widespread use for the first time.
The 2024 winners also include the project “Bifunctional Peptides to Combat Pathogens” by the team led by Dr. Anja Himmelstein and Dr. Marius Hittinger from Freie Universität Berlin and the start-up MucoSaTec. The patent includes novel bifunctional peptides, which provide a flexible and cost-effective method for fighting viral infections. The peptides bind both to the pathogen and to the mucous membranes of the body and thus immobilize the microbes.
The third prize went to the “FungiMAB” project by the team led by PD Dr. med. Niklas Beyersdorf and Dr. Daniela Langenhorst and from the University of Würzburg. The patent describes novel monoclonal antibodies that act specifically against immune evasion proteins from fungal pathogens. This overrides their very own function of deceiving the immune system. This platform technology thus creates completely new approaches for treating fungal infections.
The laudatory speeches for the respective prize winners were once again given by the prize money sponsors. This year, it was Dr. Christine Schreiber from Springer Nature, Dr. Florian Rückerl from Dehmel-Bettenhausen Patentanwälte and Dr. Angelika Vlachou from High-Tech Gründerfonds.
In addition, the finalists once again had the opportunity to win another award — the Audience Award 2024. Following the presentations, the audience was able to vote for their favorite project via online voting. Dr. Uwe Freudenberg from Dresden emerged as the audience winner with his project “Polymer Materials to Cure Inflammatory Diseases.”
Dr. Andreas Schneider and Dr. Benjamin Aberle from Stuttgart completed the field of finalists with their project “New to nature production of terpenes from cyclases” and Dr. Nikolai Jaschke from Dresden with the topic “CBP/p300 HAS inhibition for the treatment of neutropenic fever.” Dr. Julia Behnke, who won the 2019 Innovation Prize and reported on her future journey since then, also gave an exciting impetus.
Dr. Cathrin Dierkes and André van Hall from the organizing BioRegions BioIndustry and BioCologne moderated the award ceremony. “We are pleased that, with the Working Group of Bioregions, we can once again contribute to providing innovative cutting-edge research from Germany a platform and thus becoming more visible,” says Cathrin Dierkes enthusiastically. André van Hall adds: “Fortunately, the basis of German biotechnology remains excellent. It is important to consistently develop the framework conditions for the sustainable success of biotechnology. ”
About the Innovation Prize
The Innovation Prize of the German BioRegions is an initiative of the Working Group of BioRegions. Each year, the working group honors the three most innovative (patented) research ideas in the life sciences. For example, the Innovation Prize of the German BioRegions promotes transfer between science and industry and strengthens public interest in biotechnological research.
More information: www.innovationspreis-der-bioregionen.de
About the BioRegions Working Group
The Working Group of BioRegions in Germany is a voluntary association of the German BioRegions and has its office at BIO Germany in Berlin. The 31 members deal with topics such as financing, start-up and technology transfer as well as the public image of the German biotechnology sector. Since 2007, AK BioRegio has been awarding the German Bioregions Innovation Prize, a nationwide competition for application-oriented ideas from universities, and, together with BIO Germany, organizes the German Biotechnology Days.
More information: www.biodeutschland.org/de/ak-bioregio.html
The Innovation Prize of the German BioRegions 2024 was sponsored by long-standing partners, Springer Verlag, Dehmel & Bettenhausen law firm and the High-Tech Gründerfonds and organized jointly by BioIndustry and BioCologne.
Press contact for the German BioRegions Working Group:
Working Group of BioRegions c/o BIO Germany e. V.
Schützenstraße 6a 10117 Berlin
email: info@ak-bioregio.org
Site: www.ak-bioregio.org
© Pictures: http://www.sera-photography.com/